Zacks45d agobearish
TransMedics Stock Dips Post Q2 Earnings Miss, Margins ContractTMDX's Q2 revenue beat and raised outlook are overshadowed by earnings miss, declining margins and sharply higher operating costs.
News
High-signal headlines only - macro events, earnings, M&A, regulatory. Listicles and analyst clickbait filtered out by default. Refreshed hourly.
53last 24h
976last 7d
109● bullish (7d)
121● bearish (7d)
212publishers
Motley Fool86d agobearish
What a $722,000 TransMedics Insider Sale Might Mean After a 45% Stock DropSpecializing in organ preservation technology, this medical device innovator reported a notable insider sale amid ongoing sector challenges.
Zacks136d agobearish
TMDX Dips After Posting Q1 Earnings & Revenue Miss, Margins FallTransMedics' Q1 revenues rise 21% on strong OCS demand, but a sharp EPS miss and margin pressure send shares down despite continued logistics growth.
Zacks136d agobearish
TransMedics (TMDX) Q1 Earnings and Revenues Miss EstimatesTransMedics (TMDX) delivered earnings and revenue surprises of -51.46% and -0.99%, respectively, for the quarter ended March 2026. Do the numbers hold clues to what lies ahead for the stock?